Mayne Pharma | MYX - Net Income

Stock Price
2.52
Daily Change
-0.01 -0.40%
Monthly
-10.00%
Yearly
-65.10%
Q1 Forecast
2.59

Mayne Pharma reported AUD-103.68M in Net Income for its fiscal semester ending in June of 2024.





Net Income Change Date
Ansell USD 23.3M 33.8M Jun/2025
Avita Medical AUD -9.92M 1.67M Jun/2025
Cochlear AUD 91.9M 113.2M Jun/2025
CSL USD 497.5M 1.51B Jun/2025
Healius AUD -12.8M 7.8M Dec/2024
Integral Diagnostics AUD 6.06M 72.81M Jun/2024
Medical Developments International AUD -105K 409K Jun/2025
Nanosonics AUD 5.46M 4.3M Jun/2025
Polynovo AUD 1.28M 1.41M Jun/2024
Ramsay Health Care AUD 120.3M 225.2M Jun/2025
ResMed USD 392.59M 44.05M Dec/2025
Sigma Healthcare AUD -6.72M 10.02M Dec/2024
Sonic Healthcare AUD 236.68M 82.29M Dec/2024
Telix Pharmaceuticals AUD -4.83M 2.54M Dec/2025